Company Filing History:
4 out of 4 
2 out of 6 
1 out of 12 
Years Active: 2009-2023
Title: Brigitte Assouline: Innovator in Cancer Therapeutics
Introduction
Brigitte Assouline is a prominent inventor based in Courbevoie, France. She has made significant contributions to the field of cancer therapeutics, holding a total of 6 patents. Her innovative work focuses on the use of antibodies to enhance the effectiveness of anti-cancer agents.
Latest Patents
Among her latest patents is a method for the delivery of an anti-cancer agent into cells expressing the O-acetylated GD2 ganglioside. This method utilizes an antibody that specifically recognizes the OAcGD2 ganglioside, thereby improving the therapeutic potential of drugs. Another notable patent involves a humanized antibody against O-acetylated GD2 ganglioside, which includes a humanized light chain variable region and a humanized heavy chain variable region. This antibody has applications in both diagnostics and therapy.
Career Highlights
Brigitte has worked with several companies throughout her career, including Cytheris and Ogd2 Pharma. Her experience in these organizations has allowed her to develop and refine her innovative ideas in cancer treatment.
Collaborations
Brigitte has collaborated with notable individuals in her field, including Michel Christian Morre and Anne Gregoire. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Brigitte Assouline is a trailblazer in the realm of cancer therapeutics, with a strong portfolio of patents that reflect her dedication to improving treatment options. Her work continues to inspire advancements in medical science.